Browse studies

Find your next paid study

3,080 recruiting studies matching your filters

SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW/ULTRA LOW MetaStatic Breast Cancer

The purpose of this research study is to see if the medication sacituzumab govitecan (SG) is effective at the currently approved dose and schedule in people wh…

Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+2 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Reshma L. Mahtani, D.O.NCT06263543

Phase 1

A Phase I Open Label, Dose Escalation Clinical Trial Assessing the Safety, Tolerability, and Feasibility of pNGVL4aCRTE6E7L2 HPV DNA Vaccine Administration Via Intramuscular TriGridTM Electroporation Delivery System to Patients With HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia

The primary goal of this phase I open label study is to determine the safety and tolerability of pNGVL4aCRTE6E7L2 DNA vaccine, as administered by intramuscular…

Human Papillomavirus Type 16Cervical Intraepithelial Neoplasia Grade IICervical Intraepithelial Neoplasia, Grade III

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT04131413

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.

Rheumatoid Arthritis (RA)Hidradenitis Suppurativa (HS)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Sonoma Biotherapeutics, Inc.NCT07123038

Phase 4

A Randomized Study of Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment

The IMPACT study is a randomized, double-blind clinical trial evaluating two commonly used intravenous medications - metoclopramide and acetaminophen - for tre…

Concussion Post SyndromeHead Trauma Injury

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Montefiore Medical CenterNCT07634393

Phase 1

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

This research study is an open-label Phase 1 Exploratory/Pilot clinical trial to measure the effects of the incretin mimetic, tirzepatide, on tissue, urine, bl…

Colorectal Cancer PreventionColorectal Adenoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Massachusetts General HospitalNCT07095517

The Ohio State University Dermatology Biorepository

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

Hidradenitis Suppurativa

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State UniversityNCT03146676

Observational

Randomized Trial of REVITALIZE: A Telehealth Intervention to Reduce Fatigue Interference Among Adults With Advanced Ovarian Cancer on PARP Inhibitors

The purpose of this study is to see whether a supportive intervention (REVITALIZE) reduces fatigue and its impact on daily life and activities for participants…

Ovarian CancerAdvanced Ovarian CarcinomaFallopian Tube Carcinoma+4 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT06710548

Phase 2

Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Compare the efficacy and tolerability of irreversible electroporation in combination with Nivolumab in patients with locally advanced pancreatic cancer.

Pancreatic Adenocarcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of LouisvilleNCT03080974

Phase 1

AN OPEN-LABEL, SINGLE-ARM, MULTI-CENTER PHASE I/IIA CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

The study (dose escalation/expansion) is being conducted to assess the safety and tolerability of SHR-A1904 in subjects with advanced solid tumors, and to dete…

Advanced Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Jiangsu HengRui Medicine Co., Ltd.NCT05277168

Observational

Improving Overactive Bladder Treatment Access and Adherence Through Personalized Behavioral Modifications and Mobile Technology-Based Interventions

Overactive bladder (OAB) and urinary incontinence (UI) are chronic debilitating and embarrassing conditions that affect 33 million Americans. Yet, both are und…

Overactive Bladder SyndromeUrinary Incontinence

Estimated

~$10 – $750

Actual pay is set by the research site.

Stanford UniversityNCT06094543

Observational

A Multisite Randomized Trial of Viral Combat: A Mobile Gaming App to Improve Adherence to PrEP

In this study, the investigators will test the mobile game, Viral Combat, for efficacy and acceptability among diverse participants, ages 15-34 years, receivin…

Medication AdherenceHIV/AIDS

Estimated

~$10 – $750

Actual pay is set by the research site.

Rhode Island HospitalNCT05762705

Phase 1

A First-in-Human, Phase 1b Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ACT Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine (ACT-IOP-003) Once Weekly or Twice Weekly Following First-Line Systemic Chemotherapy in Participants With Nonresectable Pancreatic Cancer

This study is being done to find out if delivering gemcitabine using the ACT-IOP-003 device directly to the area where the tumor is in the pancreas is safe and…

Pancreatic Adenocarcinoma Non-resectable

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Continuity Biosciences, LLCNCT07481383